JCIC Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-37
Closed -$3K 121
2020
Q3
$3K Hold
37
﹤0.01% 97
2020
Q2
$3K Hold
37
﹤0.01% 90
2020
Q1
$3K Sell
37
-47
-56% -$3.69K ﹤0.01% 95
2019
Q4
$7K Buy
+84
New +$6.9K ﹤0.01% 101
2019
Q2
Sell
-237
Closed -$19K 135
2019
Q1
$19K Buy
+237
New +$17.7K 0.01% 83
2015
Q4
Sell
-375
Closed -$18K 99
2015
Q3
$18K Hold
375
﹤0.01% 76
2015
Q2
$20K Hold
375
﹤0.01% 78
2015
Q1
$21K Buy
+375
New +$21.2K ﹤0.01% 80
2013
Q4
Sell
-334,574
Closed -$15.2M 64
2013
Q3
$15.2M Buy
334,574
+5,224
+2% +$239K 2.73% 14
2013
Q2
$14.6M Buy
+329,350
New +$14.7M 2.84% 14

Other funds holding MRK

JCIC Asset Management's MRK Position: Q4 2020 in Review

JCIC Asset Management sold out of Merck (MRK) in Q4 2020, closing a stake of 37 shares — an estimated $3K sold.

JCIC Asset Management first reported a position in MRK in Q2 2013 and held it in 10 quarters. The position peaked at $15.2M in Q3 2013. 2,708 funds tracked by Wall St. Rank hold MRK as of Q4 2020.

  • JCIC Asset Management reported no remaining Merck position as of Q4 2020 after selling out during the quarter.
  • JCIC Asset Management sold 37 Merck shares in Q4 2020, an estimated $3K.
  • JCIC Asset Management first reported a position in Merck in Q2 2013 and held it in 10 quarters.
  • JCIC Asset Management's Merck position peaked at $15.2M in Q3 2013.
  • 2,708 funds tracked by Wall St. Rank held Merck as of Q4 2020.

Based on JCIC Asset Management's 13F filing for Q4 2020, filed 23 Feb 2021.